semaglutide and green poop Poop: Causes, When to Worry & What It Means – Bolt Pharmacy Forest plot showing the effect

However, the underlying mechanism of how these drugs regulate t...

GLP-1 receptor agonists are known to suppress appetite, which can lead to a reduced intake of essential micronutrients

Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease

GLP-1 medications have changed the conversation around weight management and metabolic health